Bolt Biotherapeutics Competitors and Similar CompaniesClear all

Bolt Biotherapeutics's competitors and similar companies include Forbius, TC BioPharm, NextCure and Immunicom.
Bolt Biotherapeutics
Bolt Biotherapeutics
Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.
Forbius
Forbius
Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases.
TC BioPharm
TC BioPharm
TC Biopharm (Holdings) is a clinical-stage cell therapy company developing immunotherapy products.
NextCure
NextCure
NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
Immunicom
Immunicom
Immunicom is a company that develops and commercializes a non-drug-based cancer therapy in order to reduce treatment side effects and enhance its response rates.
Founding Date
Founding Date
2015
Founding Date
2011
Founding Date
2013
Founding Date
2015
Founding Date
2013
Type
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Redwood City, US HQ
Locations
Austin, US HQ
Montréal, CA
Locations
Holytown, GB HQ
Leiden, NL
Edinburgh, GB
London, GB
Locations
Beltsville, US HQ
Locations
San Diego, US HQ
Employees
Employees
943% increase
Employees
913% increase
Employees
41
Employees
N/A
Employees
25
Valuation ($)
Valuation ($)
25.6 m
Valuation ($)
N/A
Valuation ($)
926.7 k
Valuation ($)
39.2 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$7.9m (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
($69.2m) (FY, 2023)
Net income
N/A
Net income
(£5.9m) (FY, 2023)
Net income
($62.7m) (FY, 2023)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 177.5m
Total funding raised
N/A
Total funding raised
$ 33.2m
Total funding raised
$ 160m
Total funding raised
$ 21.9m
For sources of this data, please see the company profile

View Company Profiles

Forbius
HQ
Austin, US

Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases.

View company
TC BioPharm
HQ
Holytown, GB
Employees
41

TC Biopharm (Holdings) is a clinical-stage cell therapy company developing immunotherapy products.

View company
NextCure
HQ
Beltsville, US

NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.

View company
Immunicom
HQ
San Diego, US
Employees
25

Immunicom is a company that develops and commercializes a non-drug-based cancer therapy in order to reduce treatment side effects and enhance its response rates.

View company